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ABSTRACT
DNA mismatch repair (MMR) contributes to genome integrity by correcting errors 
of DNA polymerase and inducing cell death in response to DNA damage. Dysfunction 
of MMR results in increased mutation frequency and cancer risk. Clinical researches 
revealed that MMR abnormalities induce cancers of non-dividing tissues, such as 
kidney and liver. However, how MMR suppresses cancer in non-dividing tissues is 
not understood.
To address that mechanism, we analyzed the roles of MMR in non-dividing cells 
using Caenorhabditis elegans (C. elegans), in which all somatic cells are non-dividing 
in the adult stage. In this study, we used stable MMR-mutant lines with a balancer 
chromosome. First, we confirmed that deficiency of MMR leads to resistance to various 
mutagens in C. elegans dividing cells. Next, we performed drug resistance assays, 
and found that MMR-deficient adult worms were resistant to SN1-type alkylating 
and oxidizing agents. In addition, dead cell staining and reporter assays of an 
autophagy-related gene demonstrated that the cell death was autophagic cell death. 
Interestingly, this autophagic cell death was not suppressed by caffeine, implying that 
MMR induces death of non-dividing cells in an atl-1-independent manner. Hence, we 
propose the hypothesis that MMR prevents cancers in non-dividing tissues by directly 
inducing cell death.
INTRODUCTION
DNA mismatch repair (MMR) ensures genome 
integrity by correcting DNA replication and recombination 
errors [1]. MMR is highly conserved from bacteria to 
humans [2,3]. In eukaryotes, MMR starts with detection 
of mismatches by MSH2-MSH6 heterodimer (MutSα) 
followed by interacting with MLH1-PMS2 heterodimer 
(MutLα), proliferating cell nuclear antigen (PCNA), and 
exonuclease1 (EXO1), and then that complex excises 
the newly synthesized strand by exonuclease activity of 
EXO1[1]. Dysfunction in MMR results in an increased 
mutation frequency in many kinds of organisms [4]. 
MMR abnormalities in humans result in increased risks 
of cancer, including hereditary nonpolyposis colorectal 
cancer (HNPCC) [5]. It is considered that MMR-deficient 
colorectal cells rapidly accumulate mutations due to their 
high turnover, which ultimately induces carcinogenesis. 
On the other hand, it has been reported that dysfunction of 
MMR also leads to increased cancer risks in non-dividing 
tissues, such as kidney and liver [6,7]. However, it is not 
understood how MMR suppresses carcinogenesis in non-
dividing cells.
Recent studies have revealed that MMR plays key 
roles in the DNA damage response (DDR) process [8]. 
An in vitro analysis revealed that MutSα has affinity to 
O6-methylguanine, which is generated by SN1-type 
DNA alkylation [9]. Furthermore, an in vivo analysis 
using mammalian cultured cells showed that following 
recognition of the DNA lesions, MMR activates the 
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G2/M checkpoint or apoptosis pathway via the ataxia 
telangiectasia and Rad3-related protein (ATR)/ATR 
Interacting Protein (ATRIP) pathway after forming a 
complex with MutLα, PCNA, and EXO1 [10–12]. Due 
to the lack of that apoptotic pathway, MMR-deficient 
cells show resistance to SN1-type alkylating agents [13]. 
In addition to O6-methylguanine, a wide range of DNA 
lesions have been identified as substrates of MMR, such 
as apurinic/apyrimidinic (AP) sites, interstrand cross-links, 
8-oxoguanine, and UV-photoproducts [14-17]. Although 
some reports have shown the possibility that MMR can 
also function in non-dividing cells, for example, by 
noncanonical MMR, the physiological function thereof is 
not well understood [18,19].
In order to address the relationship between the 
dysfunction of MMR and carcinogenesis in non-dividing 
cells, we investigated the roles of MMR in non-dividing 
cells using the nematode Caenorhabditis elegans (C. 
elegans). C. elegans has been extensively used as a model 
organism for aging, the nervous system, and apoptosis. The 
cell fates of every cell in C. elegans have been completely 
determined, and all the somatic cells of an adult worm are 
non-dividing [20,21]. Also in C. elegans, dysfunction of 
the MMR gene results in increased mutation frequency; 
for instance, knockdown of mlh-1, the homologue of 
hMlh1, results in increased mutation frequency [22].
Recently, it was reported that in response to 
5-fluorouracil (5-FU) treatment, MMR induces expression 
of lgg-1 (C. elegans MAP1LC3 orthologue), one of the 
autophagosome genes in a manner dependent on ATL-1 
(C. elegans ATR homologue) and two AP-endonucleases, 
EXO-3 and APN-1 in C. elegans embryos [23]. 5-FU 
treatment inhibits thymidine synthetase and incorporation 
of 5-fluorodeoxyuridine in genomic DNA [24]. In that 
pathway, MMR induces autophagic cell death in response 
to 5-FU treatment in embryos, indicating that C. elegans 
MMR recognizes 5-fluorodeoxyuridine in genomic 
DNA and induces autophagic cell death. However, other 
possible substrates that could similarly induce autophagy 
have not been identified yet in C. elegans. In the present 
study, we performed drug treatments of N2 and mlh-
1(ok1917) mutant worms at various developmental stages. 
mlh-1(ok1917) worms have been used previously for 
analysis of the relationship between MMR and other DNA 
repair pathways [25,26]. We first performed screenings 
of substrates of C. elegans MMR using pachytene stage 
meiotic cells, in which apoptosis is induced in response 
to DNA damage [27]. The results revealed that mlh-
1(ok1917) pachytene stage meiotic cells showed decreased 
apoptotic cells in response to various DNA lesions, like 
mammalian cultured cells. In addition, we confirmed by 
L1 drug resistance assays that MMR induces cell cycle 
arrest or cell death in response to DNA damage in dividing 
somatic cells. We next performed drug resistance assays 
using adult worms, and found that mlh-1(ok1917) adult 
worms showed resistance to alkylating and oxidizing 
agents. In addition, the results of reporter assays of lgg-
1, one of the autophagosome genes, suggested that the 
cell death of non-dividing adult somatic cells was not 
apoptosis but autophagic cell death. Interestingly, this 
autophagic cell death was not suppressed by caffeine 
treatment, suggesting that autophagic cell death is 
independent on ATL-1. These results clearly demonstrate 
that C. elegans MMR can induce cell death in non-
dividing cells in a manner apparently different from that in 
embryos, and suggest that MMR prevents carcinogenesis 
in non-dividing tissues by inducing cell death.
RESULTS
Establishment of a stable MMR mutant worm line 
Previous studies showed that dysfunction of MMR 
results in increased mutation frequency in C. elegans 
[22]. Backcrossed msh-2(ev679::Tc1) worms have no 
abnormalities in basic phenotypes, such as growth and 
lifespan. However, they die out during serial passage in 
culture, because of accumulation of mutations [28]. These 
facts mean that a stable maintenance system for MMR 
mutants is required to analyze the function of MMR 
in DDR without disturbing background mutations. In 
previous studies, it was shown that an increased mutation 
frequency is not observed in MMR heterozygous mutants 
in various species [29,30]. Therefore, we first established 
a stable maintenance system for the MMR heterozygous 
mutant using a balancer chromosome, hT2 (Supplementary 
Figure S1). hT2 is one of the balancer chromosomes that 
prevents parts of chromosomes I and III from homologous 
recombination. In addition, the myo-2p::GFP gene and 
recessive lethal gene were inserted as markers, and we 
could maintain the heterozygous mutants by selective 
picking of GFP-positive worms [31].
C. elegans MLH-1 is a component of C. elegans 
MutLα, and knockdown of C. elegans mlh-1 results 
in increased mutation frequency [22]. We performed 
backcrossing of the mlh-1-deficient strain RB1572 
(mlh-1(ok1917)), with N2 worms (wild-type). After 
backcrossing, we crossed the worms with JK2739 (lin-
6(e1466) dpy-5(e61) I/hT2 [bli-4(e937) let-?(q782) 
qIs48] (I;III)) worms to maintain the MMR mutant line 
in genetically stable condition (mlh-1(ok1917/hT2)). We 
maintained mlh-1(ok1917/hT2) worms by picking GFP-
positive worms until use and isolated mlh-1(ok1917/
ok1917) worms for experiments by picking GFP-negative 
worms (Supplementary Figure S1). We confirmed the 
absence of abnormalities in basic phenotypes in the 
backcrossed mlh-1(ok1917) mutant line (Supplementary 
Figure S2). 
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mlh-1(ok1917) pachytene stage meiotic cells 
showed decreased apoptosis in response to a wide 
range of DNA-damaging agents
In previous research, it was reported that 
MMR induces autophagic cell death in response to 
5-FU treatment in a manner dependent on two AP 
endonucleases, EXO-3 and APN1, in C. elegans embryos 
[23]. 5-FU induces genome instability by incorporation 
of 5-fluorodeoxyuridine into genomic DNA during DNA 
replication [32]. Therefore, 5-FU is not suitable for our 
research focused on the function of MMR in the DNA 
damage response in non-dividing cells. In order to identify 
other possible substrates, we measured the number of 
apoptotic pachytene stage meiotic cells. In C. elegans, 
apoptosis in pachytene stage meiotic cells is frequently 
induced by DNA damage and causes the formation of 
condensed structures in the gonad that are easily detected 
by DIC microscopy [33]. We treated synchronized adult 
worms for 24 hours with various drugs, and measured 
the number of apoptotic cell corpses of pachytene stage 
Figure 1: MLH-1 deficiency leads to resistance to various mutagens in pachytene stage meiotic cells. (A-E) The number of 
pachytene stage meiotic cells’ death of N2 and mlh-1(ok1917). The number of pachytene stage meiotic cells’ death was measured following 
24-hour drug treatment. Adult worms were treated with (A) 0.25 mM MNNG, (B) 25 mM NaHSO3, (C) 10 mM MV, (D) 0.2 mg/ml MMC, 
or (E) 0.05% MMS for 24 hours at 20oC. After the treatments, dead pachytene stage meiotic cells were counted by DIC microscopy. (F and 
G) The number of germline corpses after 24 hours of irradiation. Adult worms were irradiated with (F) 150 J/m2 UVC or (G) 100 Gy γ-rays. 
Germ cell corpses were counted by DIC microscopy 24 hours after irradiation. All data represent the mean ± 95% confidence interval from 
three independent experiments. * indicates p-value<0.05 by the Mann-Whitney U-test. A photograph of a worm was obtained from the 




is an SN1-type alkylating agent that is frequently used 
in research on MMR-dependent cell death and cell cycle 
arrest. MNNG mainly generates O6-methylguanine 
via SN1-type alkylation in genomic DNA [9]. MNNG 
treatment increased the number of apoptotic pachytene 
stage meiotic cells in N2 gonad arms, but such an increase 
was not observed in the mlh-1(ok1917) gonad arms 
(Figure 1A). These results indicate that C. elegans MMR 
induces apoptosis in response to MNNG treatment, as it 
does in mammalian cultured cells.
In addition, we also tested the following types 
of DNA-damaging agents: SN2-type alkylating agent, 
deaminating agent, oxidizing agent, cross-linking agent, 
UVC, and γ-rays. Methyl methanesulfonate (MMS) is an 
SN2-type alkylating agent, and in contrast to SN1-type 
alkylating agents mainly generates unstable DNA lesions 
such as 7-methylguanine and 3-methyladenine, which are 
easily converted to AP sites [34]. Mitomycin C (MMC) 
is a cross-linking agent that generates interstrand cross 
linking in genomic DNA [35]. Methyl viologen (MV), 
which is also called paraquat, is a superoxide-inducing 
agent, and generates oxidative DNA lesions in genomic 
DNA [36,37]. Sodium hydrogen sulfite (NaHSO3) is a 
deaminating agent that generates deaminated DNA lesions 
such as uracil and 5-(hydroxymethyl) uracil in genomic 
DNA [38]. UVC irradiation induces dimerization of 
pyrimidine bases [39]. These DNA-damaging agents have 
been reported to be activators of MMR in previous studies 
[9, 14-17]. Pachytene stage meiotic cells of mlh-1(ok1917) 
showed less apoptosis than those of N2 worms in response 
to all of the types of DNA-damaging treatments which we 
tested, except γ-rays irradiation (Figures 1B-F). These 
results suggest that C. elegans MMR can induce cell 
death in response to various base modifications. However, 
γ-rays irradiation induced a similar increase of death of 
pachytene stage meiotic cells in N2 as in mlh-1(ok1917) 
(Figure 1G). This is considered to have been due to the 
cytotoxicity of DNA double-strand breaks (DSBs) induced 
by γ-rays.
C. elegans MMR regulated larval development
Microarray experiments revealed that C. elegans 
MMR genes msh-2, msh-6, mlh-1 and pms-2 are 
abundantly expressed in pachytene stage meiotic cells 
and embryos, and their expression levels are decreased 
after hatching by approximately 10-fold, except for that 
Figure 2: mlh-1(ok1917) worms showed increased percent growth under mutagen treatment. The synchronized starved L1 
larvae of N2 and mlh-1(ok1917) were treated with (A) 0.6 mM MNNG, 60 mM NaHSO3, 40 mM MV, or 0.05% MMS and (B) irradiated 





from the normalized percent growth (L1 to L4). Error bars show 95% confidence interval. * indicates p-value<0.05 by Student’s t-test. A 
photograph of a worm was obtained from the Togo picture gallery (http://g86.dbcls.jp/~togoriv/). ©2011 DBCLS Licensed under a Creative 
Commons Attribution 2.1 Japan License.
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of pms-2 [40,41]. Next, we examined whether C. elegans 
MMR induces cell death or cell cycle arrest in post-
embryonic cells, dividing somatic cells (dSCs), using 
L1 larvae. C. elegans larvae develop to adult worms 
through 4 stages or molts, which are designated as L1, 
L2, L3 and L4. We synchronized worms at L1 stage and 
performed a time-course of treatment with various DNA-
damaging agents. Four days after the drug treatments, 
we measured the growth (percentage) from L1 larvae 
to the L4-adult stages, and calculated the half maximal 
inhibitory time (IT
50
) or dose (ID
50
) from three-parameter 
logistic curves (Supplementary Figure S3). mlh-1(ok1917) 




 in response 
to MNNG, NaHSO3, and UVC than N2 larvae (Figures 
2A and B). This suggests that C. elegans MMR induces 
cell cycle arrest or cell death in dSCs. In contrast, no 
significant difference was observed in the sensitivity to 
MV or MMS between N2 and mlh-1(ok1917) (Figure 
2A). Such a difference was observed for the msh-
6(pk2504) mutant (Supplementary Figures S4A and B). 
The observed difference of response suggests that there 
may be differential responses to DNA damage between 
pachytene stage meiotic cells and proliferating larval cells, 
although this difference may just be due to differences 
of drug penetrance or replication stress. In addition, we 
tested MMC and γ-rays, and found that they did not affect 
percentage growth significantly at the maximum doses 
used, 0.2 mg/ml and 100 Gy, respectively, in either N2 or 
mlh-1(ok1917) L1 larvae (data not shown).
C. elegans MMR induced non-dividing cell death 
in response to DNA damage
We confirmed that C. elegans MMR induces cell 
death or cell cycle arrest in post embryonic cells, dSCs, in 
response to some mutagens, including MNNG. Next, we 
examined the drug resistance of non-dividing somatic cells 
(ndSCs) using adult worms. We prepared fully matured 
adult worms by culturing synchronized L1 larvae on NGM 
plates for 4 days, and treated them with DNA-damaging 
Figure 3: MMR induced organism death independent of DNA replication. The adult worms of N2 and mlh-1(ok1917) were 
treated with (A) 3.4 mM MNNG, (B) 200 mM MV, or (C) 0.1 M NaHSO3 for 1 hour at 20oC. After the treatment, worms were cultured for 
24 hours at 20oC and the survival rate was calculated. All data represent the mean ± S.D. from three independent experiments. * indicates 
p-value<0.05 by Student’s t-test. A photograph of a worm was obtained from the Togo picture gallery (http://g86.dbcls.jp/~togoriv/). ©2011 
DBCLS Licensed under a Creative Commons Attribution 2.1 Japan License.
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agents for 1 hour. 24 hours after the drug treatments, we 
measured survival rate. As shown in Figures 3A and B, 
mlh-1(ok1917) adult worms showed a significantly higher 
survival rate than N2 worms after the MNNG and MV 
treatments. Moreover, no significant difference of the 
sensitivity to NaHSO3 treatment was observed (Figure 
3C).
In order to address whether C. elegans MMR 
induces ndSCs’ death, we performed acridine orange 
(AO) staining. AO is a non-fluorescent dye that shows 
fluorescence when it binds stably to nucleic acids. Because 
AO is actively exported out of living cells, fluorescence is 
observed only in dead cells after sufficient destaining [42]. 
As shown in Figures 4A and B, there were significantly 
fewer worms with AO fluorescence in mlh-1(ok1917) 
than in N2 in the cases of MNNG and MV treatment. 
In contrast, the same levels of AO fluorescence were 
observed in the case of NaHSO3 treatment (Figures 4A and 
B). Moreover, AO-induced fluorescence was especially 
observed in the pharynx and intestines of N2 worms after 
MV treatment, whereas there was no such localization of 
the fluorescence of mlh-1(ok1917) worms (Figure 4A). As 
shown in Figure 4C, MNNG treatment induced not only 
pharynx cell death but also death of the surrounding cells, 
while MV treatment induced only pharynx cell death in 
the head part. In C. elegans, the pharynx is in the head 
part, and neurons are located surrounding the pharynx. 
These results suggest that MNNG and MV especially 
injure neurons and intestine, respectively, in an MMR-
dependent manner in C. elegans.
Figure 4: MMR induced tissue-specific cell death. (A) MLH-1 deficiency suppressed cell death. The adult worms of N2 and 
mlh-1(ok1917) were non-treated or treated with 3.4 mM MNNG, 200 mM MV or 0.1 M NaHSO3 for 1 hour at 20
oC. After the treatment, 
worms were stained with AO for 5 minutes at 20oC and observed microscopically after destaining two times with M9 buffer and fixing with 
PFA. (B) The fraction of animals with somatic AO fluorescence. All data represent the mean ± S.D. from three independent experiments. * 
indicates p-value<0.05 by Student’s t-test. (C) A more highly magnified image of AO-stained N2 worms. White arrows indicate the location 
of each organ.
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C. elegans MMR induced autophagic cell death in 
ndSCs independently of ATL-1
In humans, MMR induces apoptosis or cell cycle 
arrest via the ATR/ATRIP pathway [11]. In response to 
damage recognition by MutSα, ATR/ATRIP is activated 
and phosphorylates CHK1 to induce cell cycle arrest and 
CHK2 to induce apoptosis [11,12]. In C. elegans, this 
system is well conserved, and it has been reported that in 
Figure 5: MMR induced autophagic cell death. (A) Reporter assays of lgg-1. Synchronized MAH236 (lgg-1p::GFP::lgg-1) adult 
worms cultured on control or RNAi plates were treated with 1.7 mM MNNG, 50 mM MV or 50 mM NaHSO3 for 7 hours at 20
oC. After the 
treatments, worms were fixed with PFA. After washing two times with M9 buffer, worms were examined microscopically. (B) The fraction 
of animals with increased somatic GFP. All data represent the mean ± S.D. from three independent experiments. * indicates p-value<0.05 
by Student’s t-test. At least 150 animals were observed in each condition. (C) Enlarged images of (a) MNNG-treated and (b) MV-treated 
MAH236 worms cultured on control plates. (D) Semi-quantitative RT-PCR of MNNG-treated worms. The adult worms of wild-type or 
ok1917 germline deficient worms (glp-4(bn2)) were treated with 1.7 mM MNNG for 7 hour at 20oC. Then, total RNA was purified and 
reverse transcribed. The expression levels of vps-34 were determined by semi-quantitative RT-PCR. tbg-1 was used as the loading control. 
A photograph of a worm and microscopic images were obtained from the Togo picture gallery (http://g86.dbcls.jp/~togoriv/). ©2011 
DBCLS Licensed under a Creative Commons Attribution 2.1 Japan License.
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C. elegans embryos, MMR activates CHK-1 (C. elegans 
CHK1 homologue) and induces autophagic cell death in 
response to 5-FU treatment in an ATL-1-dependent manner 
[23]. In order to examine how MMR induces cell death in 
ndSCs, we next tried to identify the type of cell death. In 
C. elegans, the cascade of apoptosis is well understood, 
and is regulated by only 4 factors: CED-3, CED-4, CED-
9, and EGL-1. CED-3 is the effector caspase, and is 
converted to the active form by CED-4. Usually, CED-4 is 
blocked by CED-9, but only when cells undergo apoptosis, 
CED-4 activates CED-3 as a result of inhibition of CED-
9 by EGL-1. egl-1 is one of the genes whose expression 
is regulated by CEP-1 (the C. elegans p53 homologue) 
and is responsible for apoptosis in pachytene stage meiotic 
cells [43]. To determine whether the cell deaths in ndSCs 
were due to apoptosis, we measured somatic egl-1 mRNA 
levels in MNNG-treated worms by semi-quantitative 
RT-PCR using the temperature-sensitive sterile mutant 
glp-4(bn2) cultured at 25oC, which does not have 
gonads, but no significant induction of egl-1 mRNA was 
detected, whereas Wt worms, which have gonads, showed 
increased egl-1 mRNA in response to MNNG treatment 
(Supplementary Figure S5).
We then focused on autophagic cell death. 
Autophagic cell death is also known as type 2 cell death, 
and is defined as cell death with autophagy rather than 
apoptosis [44,45]. In humans, MAP1LC3 (ATG8) is 
widely used as a marker of autophagic cell death. In 
mammalian cells, MAP1LC3 exists in two forms: full-
length form MAP1LC3-I (MAP1LC3) and shorter-form 
MAP1LC3-II [45]. During autophagy, MAP1LC3-I is 
transformed to MAP1LC3-II by cleavage, and MAP1LC3-
II localizes to membranes of autophagosomes [45]. In the 
process of autophagic cell death, MAP1LC3 is specifically 
upregulated [44,45]. This system is well conserved also 
in C. elegans, and upregulation of lgg-1 in the process 
of autophagic cell death has been reported [23]. Based 
on these facts, we used lgg-1 expression as a marker of 
autophagic cell death, and we performed reporter assays 
using MAH236 (lgg-1p::GFP::lgg-1) worms. Because 
of the expressed GFP::LGG-1, we could not use a stable 
maintenance system using a GFP balancer. Therefore, we 
performed reporter assays using msh-2 knockdown worms 
(Supplementary Figure S6). As shown in Figures 5A and 
B, the expression level of lgg-1 was elevated by MNNG 
and MV treatments, and knockdown of msh-2 suppressed 
this induction, whereas there was no difference between 
the NaHSO3-treated control and msh-2 knockdown 
worms. LGG-1 was expressed in the pharynx and intestine 
in MV-treated N2 worms, but only in the pharynx and 
surrounding cells in MNNG-treated N2 worms (Figure 
5C). In addition, we analyzed the mRNA levels of vps-
34, a homologue of human class III PI3K, which is 
expressed during autophagic cell death in C. elegans, and 
we confirmed that mRNA levels of vps-34 were increased 
in response to MNNG treatment (Figure 5D) [23]. These 
results suggest that MMR induces autophagic cell death in 
ndSCs in response to MNNG and MV treatment.
There are two hypotheses about how MMR induces 
cell death: “futile repair” and “signaling” [8]. In futile 
repair, repeated excision and resynthesis occur, and 
they lead to DSBs and genome instability [46]. It has 
been reported that MNNG generates DSBs in an MMR-
dependent manner, and a DSB repair mutant shows 
sensitivity to MNNG [47,48]. Ataxia telangiectasia 
mutated (ATM) is a member of the PIKK family, and it is 
required for DSB repair, homologous recombination, non-
homologous end-joining, and alternative end-joining [49]. 
In C. elegans, ATM-1, a homologue of ATM, also plays 
a critical role in DSB repair [50,51]. In order to analyze 
whether DSBs are generated by MNNG treatment, we 
performed drug resistance assays using atm-1(tm5027) 
worms. In C. elegans, atm-1(tm5027) L1 larvae showed 
sensitivity to both MNNG and MMS, but the sensitivity 
to MNNG was abrogated by deficiency of mlh-1, whereas 
the sensitivity to MMS was not (Supplementary Figure 
S7, Figure 6A). MNNG generates relatively stable DNA 
lesions such as O6-methylguanine, whereas MMS induces 
DSBs via accumulation of AP sites, which are converted 
to SSBs by AP endonucleases. From these facts, it is 
considered likely that MNNG induced DSBs in an MMR-
dependent manner in dSCs, suggesting the presence of 
futile repair in dSCs. In contrast, adult worms did not show 
sensitivity to MNNG although they showed sensitivity to 
MMS (Figure 6B). This means that MNNG can not induce 
DSB in ndSCs, suggesting the absence of futile repair in 
ndSCs. Therefore, C. elegans MMR can induce cell death 
via both futile repair and signaling depending on the types 
of cell or stages.
During futile repair, in order to protect the template 
single-strand DNA, replication protein A (RPA) is 
accumulated on the template strand. This RPA recruits 
ATR, and the recruited ATR activates the signaling cascade 
[52]. This suggests that ATR may not be required for 
“signaling” cell death. Accordingly, we examined whether 
ATL-1 is responsible for ndSCs death. In C. elegans, the 
knockout of atl-1 results in lethality. For this reason, we 
can not use an atl-1 null mutant, although we can use an 
atl-1 heterozygous mutant (tm853/nT1). This means that 
we could only decrease the atl-1 expression level to only 
about 50% by either knockout or knockdown. In order 
to more efficiently inhibit ATL-1, we performed caffeine 
treatment. Caffeine is widely used as an inhibitor of ATM 
and ATR proteins, and in a previous study, treatment with 
20 mM caffeine for at least 6 hours decreased the ATL-1 
activity in C. elegans [53]. In our experiments, caffeine 
treatment did not inhibit expression of LGG-1, but rather 
appeared to slightly promote it under conditions of MNNG 
treatment (Figure 6C and D). These results suggest that 




In the present study, we demonstrated that C. 
elegans MMR induces autophagic cell death in response 
to DNA damage in non-dividing cells. Previous studies 
showed that MMR-induced cell death and cell cycle arrest 
Figure 6: MMR induces autophagic cell death in an ATR-independent manner. (A) IT
50
 of L1 larvae of N2, atm-1(tm5027) 
and atm-1(tm5027)/mlh-1(ok1917). The synchronized starved L1 larvae of N2, atm-1(tm5027) and atm-1(tm5027)/mlh-1(ok1917) were 





 from the normalized percent growth (L1 to L4). IT
50
 was obtained from the logistic curve. Error bars show 95% 
confidence interval. * indicates p-value<0.05 by Student’s t-test. (B) atm-1(tm5027) adult worms did not show sensitivity to MNNG. The 
adult worms of N2 and atm-1(tm5027) were treated with 3.4 mM MNNG or 0.5% MMS for 1 hour at 20oC. After the treatment, worms 
were cultured at 20oC. Twenty-four hours later, the survival rate was calculated. All data represent the mean ± S.D. from three independent 
experiments. * indicates p-value < 0.05 by Student’s t-test. (C) Caffeine inhibition assay. Caffeine-treated (20 mM caffeine for at least 
6 hours) lgg-1 synchronized MAH236 (lgg-1p::GFP::lgg-1) adult worms cultured on control or RNAi plates were treated with 1.7 mM 
MNNG, 50 mM MV or 50 mM NaHSO3 for 7 hours at 20
oC. After the treatments, worms were fixed with PFA. After washing two times 
with M9 buffer, worms were examined microscopically. (D) The fraction of animals with increased somatic GFP was measured. All data 
represent the mean ± S.D. from three independent experiments. * indicates p-value<0.05 by Student’s t-test.
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are responsible for genome integrity and cancer prevention 
in mammalian dividing cells [4]. On the other hand, some 
reports showed that MMR factors are also present in 
non-dividing cells and MMR prevents carcinogenesis in 
non-dividing cells, such as kidney and liver [54]. Some 
reports showed DNA replication-independent functions 
of MMR, such as non-canonical MMR, which usually 
result in inaccurate DNA repair and induce mutations 
and cancers [18,19]. These facts are not in accord with 
clinical observations, and how MMR prevents cancers of 
non-dividing cells has remained unclear. Our finding that 
MMR induces cell death in non-dividing cells in response 
to DNA damage suggests one possible function of MMR 
in the prevention of carcinogenesis in non-dividing cells.
A recent study showed that 5-FU treatment induces 
autophagic cell death in an MMR- and AP endonuclease-
dependent manner in C. elegans embryos, but other 
substrates of C. elegans MMR have not been identified 
[23]. In order to analyze the functions of C. elegans MMR, 
we first tried screening the substrates of C. elegans MMR 
using pachytene stage meiotic cells. These screenings 
showed that mlh-1(ok1917) pachytene stage meiotic cells 
have a deficiency of apoptosis induced by a wide range of 
DNA-damaging agents, such as MNNG and UVC (Figure 
1). This suggests that C. elegans MMR, similarly to 
MMR in mammalian cultured cells,  induces apoptosis in 
response to a wide range of DNA lesions, for example, O6-
methylguanine, AP sites, and thymine dimers [9,14–17]. 
In contrast, mlh-1(ok1917) pachytene stage meiotic cells 
showed induction of normal levels of apoptosis by γ-rays 
irradiation (Figure 1G). While γ-rays irradiation generates 
reactive oxygen species (ROS), such as superoxide, γ-rays 
irradiation also directly induces DNA double-strand breaks 
[55]. As shown in Figure 1C, mlh-1(ok1917) pachytene 
stage meiotic cells can undergo induction of apoptosis in 
response to MV, which generates superoxide, indicating 
that C. elegans MMR responds to oxidative DNA damage 
caused by superoxide. Thus, γ-rays irradiation induced cell 
death not in response to oxidative lesions, but rather in 
response to more toxic DSBs.
In C. elegans, MMR factors are abundantly 
expressed in germ cells and embryos, while they are 
not as highly expressed in postembryonic somatic cells 
[40,41]. To examine whether C. elegans MMR works 
in postembryonic somatic cells, we measured the drug 
resistance during growth, and found that the development 





in response to some kinds of DNA-damaging agents 
compared to N2 larvae (Figures 2A and B). This means 
that C. elegans MMR induces cell death or cell cycle 
arrest in dividing somatic cells (dSCs), and deficiency 
of MMR results in DNA-damage-resistant growth of L1 
larvae.
Next, we performed drug resistance assays using 
adult worms, and found that mlh-1(ok1917) adult worms 
are resistant to MNNG and MV treatments (Figures 3A 
and B). This suggests that C. elegans MMR induces non-
dividing somatic cells’ (ndSCs’) death. In order to confirm 
whether MMR induces ndSCs’ death, we performed AO 
staining. The results of AO staining suggested that C. 
elegans MMR induced cell death in response to the drug 
treatments in ndSCs such as those in pharynx, intestine 
and neurons (Figure 4). These results indicate that C. 
elegans MMR induces cell death independently of DNA 
replication.
In addition, we obtained interesting findings 
about the mechanism of cell death induced by MMR. In 
eukaryotic organisms, two models have been suggested 
for the mechanisms underlying MMR-induced cell death: 
“futile repair” and “signaling” [8]. In a previous study, it 
was shown that EXO1 is essential for inducing cell death 
by MMR in mammalian cultured cells, but the exonuclease 
activity of EXO1 is not required [10]. This suggests that 
MMR can induce cell death just by signaling, without 
futile repair. In our experiments, atm-1(tm5027) L1 larvae 
showed sensitivity to both MNNG and MMS (Figure 6A). 
On the other hand, atm-1(tm5027) adult worms did not 
show sensitivity to MNNG, whereas they were sensitive 
to MMS (Figure 6B). These results suggest that MNNG 
treatment generates DSBs in dSCs, but not in ndSCs. 
In addition, the sensitivity to MNNG in L1 larvae was 
abrogated by deficiency of MLH-1 (Figure 6A). Based on 
these facts, we hypothesize that MMR induces cell death 
by futile repair and/or signaling in dividing cells, and by 
only signaling in non-dividing cells.
In futile repair, RPA is accumulated on single-strand 
DNA, and RPA recruits ATR/ATRIP. Therefore, the fact 
that MMR can induce cell death by just signaling suggests 
that MMR can induce cell death independently of ATR/
ATRIP in non-dividing cells. To examine the necessity 
for ATR/ATRIP in ndSCs’ death, we performed caffeine-
inhibition assays of the induction of LGG-1 using adult 
worms. The results of caffeine inhibition assays suggested 
that C. elegans MMR induced autophagic cell death 
independently of ATL-1, which means that C. elegans 
MMR induced autophagic cell death in ndSCs in an 
apparently different manner from that in embryos (Figures 
6C and D) [23]. 
In HeLa cells, the MAPO1/AMPK pathway has been 
identified as a pathway that induces apoptosis in response 
to SN1-type alkylating agents in an MMR-dependent 
manner [56]. These factors are highly conserved among 
higher eukaryotes, and also in C. elegans. The fact that 
p53 is inactivated in HeLa cells implies that the MAPO1/
AMPK pathway may also not require ATR/ATRIP. 
Furthermore, AMPK regulates autophagy via inhibition 
of mTOR, whose activity is not inhibited by caffeine, and 
indeed rather is promoted by it [57]. This is in accord with 
the results of our caffeine inhibition assay (Figure 6D), 
and implies that C. elegans MMR induces autophagic cell 
death via AMPK/mTOR in ndSCs.
As another possibly significant feature of autophagy 
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induced by MMR, it is considered that MMR may prevent 
the accumulation of abnormal proteins. DNA lesions can 
induce not only replication errors but also transcription 
errors. Therefore, severe damage of genomic DNA leads to 
accumulation of abnormal proteins. MMR may contribute 
to the maintenance of cell function by surveying DNA 
lesions and inducing autophagy to degrade abnormal 
proteins.
We obtained the interesting findings that the 
sensitivity of mlh-1(ok1917) cells differed among 
pachytene stage meiotic cells, dSCs, and ndSCs (Figures 
1-3). In addition, MMR induced autophagic cell death 
in different tissues in response to MNNG versus MV 
(Figures 4 and 5). In humans, MutSα has SQ/TQ 
sites, and the kinase inhibitor UCN-01 decreases the 
phosphorylation levels of MutSα and its binding affinity 
to O6-methylguanine [9]. Even though our findings might 
have been due simply to differences of drug penetration 
or just the difference of the presence or absence of 
DNA replication, which induces genome instability via 
replication stress, these differences may mean that MMR 
components may be appropriately modified depending 
on the growth stage or tissue in order to efficiently and 
appropriately protect each tissue. For example, C. elegans 
MMR can recognize more kinds of DNA damage in 
pachytene stage meiotic cells than in somatic cells, and 
this may be due to the various modifications of C. elegans 
MutSα in order to enable precise inheritance of the 
genomic information.
Recently much attention has been paid to dormant 
cancer cells. These cells are considered to be cancer 
stem cells and to show resistance to many anticancer 
agents. These cells are thought to be a cause of recurrent 
carcinoma because of the difficulty associated with 
killing them [58]. This resistance may be derived from 
differences in the DDR pathways between dividing and 
non-dividing cells. DDR pathways in non-dividing cells 
need to be examined in more detail. The results of the 
present study may represent a breakthrough for cancer 
therapy for dormant cancer stem cells.
MATERIALS & METHODS
Construction of a knockdown vector
The sequence information of H26D21.2 (Cemsh-2) 
was obtained from the NCBI database. PCR was conducted 
using two PCR primers listed in the Supplementary Table 
and KOD-Plus- polymerase (TOYOBO, Japan). The 
amplified products were digested with Bgl II and Hind III 
for cloning an approximately 1-Kbp fragment from the 5’ 
end. The digested products were then ligated to the L4440 
vector digested with BamH I and Hind III.
C. elegans strains and culture conditions
The wild-type strain (Bristol N2), RB1572[mlh-
1(ok1917) III], JK2739[lin-6(e1466) dpy-5(e61) I/hT2 
[bli-4(e937) let-?(q782) qIs48] (I;III)], NL2511[msh-
6(pk2504) I], MAH236; [lgg-1p::GFP::lgg-1 + odr-
1p::RFP]), and SS104 [glp-4(bn2)I] were supplied by the 
Caenorhabditis Genetics Center (Minneapolis, USA). 
atm-1(tm5027) mutant was supplied by the National 
BioResource Project (Tokyo, Japan). A deletion was 
verified in the mlh-1 and atm-1 genes by PCR using 
two primer pairs listed in the Supplementary Table. 
RB1572, NL2511 and atm-1(tm5027) mutant worms were 
backcrossed with Bristol N2 two times and maintained 
with the GFP balancer hT2 to avoid the accumulation 
of mutations [31]. lgg-1 reporter strain (tm5027 [lgg-
1p::GFP::lgg-1 + odr-1p::RFP]), atm-1(tm5027)/mlh-
1(ok1917) double mutant and balanced germline mutant 
[mlh-1(ok1917) glp-4(bn2) lin-6(e1466) dpy-5(e61) I/
hT2 [bli-4(e937) let-?(q782) qIs48] ], were generated by 
crossing each strain. Worms were cultured at 20°C on 
50-mm NGM plates containing 0.3% (w/v) NaCl, 0.25% 
(w/v) polypeptone, 0.005% (w/v) cholesterol, 1 mM 
MgSO4, 1 mM CaCl2, 25 mM potassium phosphate (pH 
6.0), and 0.17% (w/v) agar with a lawn of Escherichia coli 
(E. coli) OP50 [59]. 
Synchronization of worms
Starved L1 larvae were prepared in order to obtain 
synchronized worms. Briefly, worms on NGM plates 
were harvested by washing out with distilled water and 
incubated in alkaline hypochlorite [500 mM NaOH 
and 1.2% (v/v) hypochlorite] until their bodies were 
completely dissolved (5-10 minutes). Eggs were then 
washed three times with S basal [50 mM potassium 
phosphate, (pH 6.0), containing 100 mM NaCl]. The eggs 
were hatched and synchronized by incubation at 20oC 
overnight without food [59].
Measurement of lifespan
Synchronized L1 larvae were cultured on NGM 
plates until they developed to the adult stage (3 days). 
To determine lifespans, worms were harvested with M9 
buffer (22 mM KH2PO4, 42 mM Na2HPO4, l mM MgSO4, 
85 mM NaCl) and transferred to 50-mm NGM plates 
containing 10 µg/ml 5-fluoro-2’-deoxyuridine with a lawn 
of E. coli OP50. Worms that failed to move spontaneously 
or respond to touch were counted as dead. Worms were 
counted every 2 days [60]. 
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L1 growth assay
The time-course drug treatments were performed 
using synchronized L1 worms in M9 buffer containing 
various drugs at 20 oC. Then, worms were transferred to 
NGM plates and incubated for 4 days. UVC irradiation 
was performed to synchronized L1 worms, and then 
worms were incubated for 4 days. After 4 days, the 
percentage of worms that grew from L1 to adults was 
calculated, and the half-maximal inhibitory time or dose 
was obtained by the three-parameter logistic curve using R 
[55]. At least 200 animals were counted in each condition.
Quantification of germ line apoptosis
Synchronized L1 larvae were cultured on NGM 
plates until they developed to the young adult stage (2 
days). They were harvested with M9 buffer and then 
treated with various DNA-damaging agents in M9 buffer 
at 20oC for 24 hours. Worms were then immobilized in M9 
buffer containing 20 mM sodium azide and observed using 
a differential interference contrast (DIC) microscope [33]. 
At least 150 gonad arms were counted in each condition.
Adult worm drug resistance assay
Synchronized L1 larvae were cultured on NGM 
plates until they completely developed to the adult stage 
(4 days). They were harvested with M9 buffer and then 
treated with various DNA-damaging agents in M9 buffer 
for 1 hour at 20oC. They were transferred to NGM plates 
and incubated for 1 day, and the survival rate was then 
calculated. At least 200 animals were counted in each 
condition.
AO staining
Synchronized L1 larvae were cultured on NGM 
plates until they developed completely to the adult stage 
(4 days). Adult worms were harvested with M9 buffer, 
and treated with various DNA-damaging agents in M9 
buffer for 1 hour at 20oC. Worms were then washed with 
M9 buffer two times and stained with 5 mg/ml acridine 
orange (AO) in M9 buffer for 5 minutes. Worms were 
destained two times with 1 ml of M9 buffer for 10 min, 
and fixed with phosphate buffered saline (pH 7.4) (PBS) 
containing 4% paraformaldehyde (PFA). After washing 
two times with 1ml of M9 buffer, they were observed 
using fluorescence microscopy with excitation by a 488 
nm argon laser [42]. At least 150 animals were counted in 
each condition.
Feeding RNAi
Knockdown analysis was performed using standard 
feeding methods [61,62]. E. coli HT115 (DE3) was 
transformed with L4440 vectors and cultured overnight 
in Luria-Bertani (LB) medium containing 25 µg/ml 
carbenicillin (Cb), 15 µg/ml tetracycline (Tet), and 320 
µM isopropyl β-D-1-thiogalactopyranoside (IPTG) 
at 30 oC. After additional supplementation with Cb, 
Tet, and IPTG (final 50 µg/ml, 30 µg/ml, and 640 µM, 
respectively), overnight cultures were seeded on NGM 
plates (RNAi plates). Worms were primarily cultured on 
RNAi plates for 3 days. Eggs were then harvested using 
the alkaline bleach method. The eggs were transferred to 
fresh RNAi plates and allowed to develop completely to 
the adult stage (4 days). To confirm the effects of RNAi, 
reverse transcription-polymerase chain reaction (RT-
PCR) was carried out using the primer pairs listed in the 
Supplementary Table and GoTaq (Promega, USA).
Reporter assay
MAH236 worms cultured on RNAi plates were 
harvested with M9 buffer and treated with DNA-damaging 
agents for 7 hours at 20 oC in M9 buffer. Worms were 
immediately fixed with PBS containing 4% PFA for 10 
minutes at 20 oC. After washing two times with M9 buffer, 
worms were observed using fluorescent microscopy with 
excitation by a 488 nm argon laser [23]. At least 150 
animals were counted in each condition.
Semi-quantitative RT-PCR
In order to determine the expression levels, semi-
quantitative RT-PCR was carried out using the primer 
pairs listed in the Supplementary Table.
Microscopy
DIC microscopy and fluorescence microscopy were 
performed using a Carl Zeiss LSM510 microscope (Carl 
Zeiss, Germany).
Statistics
Qualitative data were representative data of at least 
three experiments. Unless otherwise noted, quantitative 
data were expressed as the mean ± S.D. The significance 
of differences was examined using Student’s t-test or the 
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